Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 7/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.34 |
| ▸ | FYN | P06241 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10053535 | 0.97 | L3MBTL1 (0.43) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL22256082 | 0.92 | L3MBTL1 (0.39) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL12856520 | 0.91 | CYP1A2 (0.40) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL12856496 | 0.90 | TDP1 (0.38) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL12856568 | 0.89 | CYP1A2 (0.37) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL13320933 | 0.89 | CYP1A2 (0.37) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL29721190 | 0.89 | CYP1A2 (0.37) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL13333766 | 0.88 | CYP1A2 (0.42) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL9429272 | 0.88 | ALDH1A1 (0.43) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL13367581 | 0.88 | ALDH1A1 (0.51) | L3MBTL1HTTNPSR1CYP2A6TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11515481-B2 | Composition for forming organic film, display device using the composition, and method of manufacturing the display device | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-11-29 | — | — | US | disclosed |
| US-20190019958-A1 | COMPOSITION FOR FORMING ORGANIC FILM, DISPLAY DEVICE USING THE COMPOSITION, AND METHOD OF MANUFACTURING THE DISPLAY DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-01-17 | — | — | US | disclosed |
| US-9024301-B2 | Organic luminescent medium and organic EL device | IDEMITSU KOSAN CO., LTD. (JP) | 2015-05-05 | — | — | US | disclosed |
| US-9024301-B2 | Organic luminescent medium and organic EL device | IDEMITSU KOSAN CO., LTD. (JP) | 2015-05-05 | — | — | US | disclosed |
| US-20130221338-A1 | ORGANIC LUMINESCENT MEDIUM AND ORGANIC EL DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2013-08-29 | — | — | US | disclosed |
| US-20130221338-A1 | ORGANIC LUMINESCENT MEDIUM AND ORGANIC EL DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2013-08-29 | — | — | US | disclosed |
| US-8450727-B2 | Organic luminescent medium and organic EL device | IDEMITSU KOSAN CO., LTD. (JP) | 2013-05-28 | — | — | US | disclosed |
| US-8450727-B2 | Organic luminescent medium and organic EL device | IDEMITSU KOSAN CO., LTD. (JP) | 2013-05-28 | — | — | US | disclosed |
| US-20110042660-A1 | ORGANIC LUMINESCENT MEDIUM AND ORGANIC EL DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2011-02-24 | — | — | US | disclosed |
| US-20110042660-A1 | ORGANIC LUMINESCENT MEDIUM AND ORGANIC EL DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2011-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110042660-A1 | ORGANIC LUMINESCENT MEDIUM AND ORGANIC EL DEVICE | AOC1, EBPL, CYBA | L3MBTL1 268/4885HTT 4773/4885NPSR1 4885/4885 |
| US-20190019958-A1 | COMPOSITION FOR FORMING ORGANIC FILM, DISPLAY DEVICE USING THE COMPOSITION, AND METHOD OF MANUFACTURING THE DISPLAY DEVICE | OCIAD1, OCIAD2, OR10J3 | L3MBTL1 4041/4885HTT 4475/4885NPSR1 3996/4885 |
| US-11515481-B2 | Composition for forming organic film, display device using the composition, and method of manufacturing the display device | OR10J3, ILK, RER1 | L3MBTL1 4388/4885HTT 4557/4885NPSR1 2616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.